marginally significantp = 0.05
A trend towards higher eczema presentation was reported in Group B infants, but the difference was marginally significant ( p = 0.05).
A trend towards higher eczema presentation was reported in Group B infants, but the difference was marginally significant ( p = 0.05).
In our study, eczema as a comorbidity presented more frequently in group B, with a difference close to significance suggesting eczema as a potential risk factor for delay FPIAP resolution.
One study evaluating infants who developed tolerance before and after 18 months of age found that a family history of any allergic disease was a highly significant risk factor for late tolerance according to univariate, but not multivariate, logistic analysis [ 23 ].